EPFL spin-off Leman Biotech has developed a protein that can improve the effectiveness of immunotherapy drugs used to treat some types of cancer. The firm has just completed its first funding round, in the amount of $11 million.

Administration

Aerial views

Architecture

Awards and distinctions

Biology

Campus

Campus Life

Cancer

CDH

CDM

Chemistry

Civil Engineering

Communication

Computer Science

Culture

Electricity

Electronic

ENAC

Energy

Environment

EPFL

EPFL Middle East

Events

Finance

HBP

IC

Infectiology

Locations

Management

Materials Science

Mathematics

Mechanical Engineering

Microengineering

Neuroscience

Office of the President

Official ceremonies

Official visits

Physics

Places

Portraits gallery

Research and Tech Transfer

Robotics

SB

Services and activities

Social and Human Sciences

Space

Startups and Industry

STI

Students

Sustainable development

SV

Swiss Plasma Center

Swiss Space Center

Teaching

Urbanism and Sociology

Media Library

Categories

Topics

Media properties